{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:43:14Z","timestamp":1793929394418,"version":"4.8.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The ability to account for comorbidity when estimating survival in a population diagnosed with cancer could be improved by using a drug comorbidity index based on filled drug prescriptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We created a drug comorbidity index from age-stratified univariable associations between filled drug prescriptions and time to death in 326,450 control males randomly selected from the general population to men with prostate cancer. We also evaluated the index in 272,214 control females randomly selected from the general population to women with breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The new drug comorbidity index predicted survival better than the Charlson Comorbidity Index (CCI) and a previously published prescription index during 11 years of follow-up. The concordance (C)-index for the new index was 0.73 in male and 0.76 in the female population, as compared with a C-index of 0.67 in men and 0.69 in women for the CCI. In men of age 75\u201384 years with CCI = 0, the median survival time was 7.1 years (95% confidence interval [CI] = 7.0, 7.3) in the highest index quartile. Comparing the highest to the lowest drug comorbidity index quartile resulted in a hazard ratio (HR) of 2.2 among men (95% CI = 2.1, 2.3) and 2.4 among women (95% CI = 2.3, 2.6).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A new drug comorbidity index based on filled drug prescriptions improved prediction of survival beyond age and the CCI alone. The index will allow a more accurate baseline estimation of expected survival for comparing treatment outcomes and evaluating treatment guidelines in populations of people with cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001358","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T01:02:06Z","timestamp":1620003726000},"page":"607-615","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":47,"title":["An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts"],"prefix":"10.1097","volume":"32","author":[{"given":"Rolf","family":"Gedeborg","sequence":"first","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Sund","sequence":"additional","affiliation":[{"name":"Department of Surgery and Perioperative Sciences\/Surgery, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Lambe","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Plym","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Urology Division, Department of Surgery, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Fredriksson","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Breast, Endocrine Tumors, and Sarcoma, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Syrj\u00e4","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Holmberg","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"},{"name":"Translational Oncology and Urology Research (TOUR), King\u2019s College London, Guy\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Urology, Ryhov Hospital, J\u00f6nk\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Garmo","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"},{"name":"Translational Oncology and Urology Research (TOUR), King\u2019s College London, Guy\u2019s Hospital, London, UK"},{"name":"Regional Cancer Center, Uppsala\/\u00d6rebro, Uppsala University Hospital, Uppsala, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13014-017-0796-x","article-title":"The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials.","volume":"12","author":"Matuschek","year":"2017","journal-title":"Radiat Oncol"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","article-title":"A chronic disease score from automated pharmacy data.","volume":"45","author":"Von Korff","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/00005650-200111000-00006","article-title":"The Medicaid Rx model: pharmacy-based risk adjustment for public programs.","volume":"39","author":"Gilmer","year":"2001","journal-title":"Med Care"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.MLR.0000064641.84967.B7","article-title":"Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument.","volume":"41","author":"Sloan","year":"2003","journal-title":"Med Care"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/1475-6773.00179","article-title":"Case-mix adjusting performance measures in a veteran population: pharmacy- and diagnosis-based approaches.","volume":"38","author":"Liu","year":"2003","journal-title":"Health Serv Res"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"e021122","DOI":"10.1136\/bmjopen-2017-021122","article-title":"The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) classification system.","volume":"8","author":"Pratt","year":"2018","journal-title":"BMJ Open"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12911-018-0586-x","article-title":"Combining information from a clinical data warehouse and a pharmaceutical database to generate a framework to detect comorbidities in electronic health records.","volume":"18","author":"Sylvestre","year":"2018","journal-title":"BMC Med Inform Decis Mak"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"e0241439","DOI":"10.1371\/journal.pone.0241439","article-title":"Prescription-based prediction of baseline mortality risk among older men in Sweden.","volume":"15","author":"Gedeborg","year":"2020","journal-title":"PLoS One"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/00001648-200111000-00017","article-title":"Paradoxical relations of drug treatment with mortality in older persons.","volume":"12","author":"Glynn","year":"2001","journal-title":"Epidemiology"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998.","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register.","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bcpt.12613","article-title":"The first decade with the Swedish Prescribed Drug Register\u2014a systematic review of the output in the scientific literature.","volume":"119","author":"Wallerstedt","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register.","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/00365590903024577","article-title":"PCBaSe Sweden: a register-based resource for prostate cancer research.","volume":"43","author":"Hagel","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ije\/dyv305","article-title":"Cohort profile update: The National Prostate Cancer Register of Sweden and prostate cancer data base\u2014a refined prostate cancer trajectory.","volume":"45","author":"Van Hemelrijck","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2169\/internalmedicine.44.710","article-title":"Severe community-acquired pneumonia in an intensive care unit: risk factors for mortality.","volume":"44","author":"Yoshimoto","year":"2005","journal-title":"Intern Med"},{"key":"R21-20250801","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation.","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.TA.0000114240.58834.84","article-title":"Risk adjustment for injured patients using administrative data.","volume":"57","author":"Clark","year":"2004","journal-title":"J Trauma"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00005373-199609000-00002","article-title":"ICISS: an international classification of disease-9 based injury severity score.","volume":"41","author":"Osler","year":"1996","journal-title":"J Trauma"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/TA.0b013e3182a9cd31","article-title":"Internationally comparable diagnosis-specific survival probabilities for calculation of the ICD-10-based Injury severity score.","volume":"76","author":"Gedeborg","year":"2014","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:07:10Z","timestamp":1754060830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001358","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,2]]}}}